Trial intelligence / Profile preview

SAR113945 in Knee Osteoarthritis

NCT01598415Phase 2Completed

Sponsor
Sanofi
Start
Apr 2012
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of SAR113945 in osteoarthritis (OA), sponsored by Sanofi. Started Apr 2012; status: completed.

02

Drugs

SAR113945
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01598415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01598415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call